ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,080 | +34.3% | 524 | +78.2% | 0.00% | – |
Q2 2023 | $10,484 | +40.4% | 294 | 0.0% | 0.00% | – |
Q1 2023 | $7,468 | -37.4% | 294 | 0.0% | 0.00% | – |
Q4 2022 | $11,925 | +19.2% | 294 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | 0.0% | 294 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | -9.1% | 294 | +25.6% | 0.00% | – |
Q1 2022 | $11,000 | -47.6% | 234 | -27.6% | 0.00% | – |
Q4 2021 | $21,000 | +40.0% | 323 | +38.0% | 0.00% | – |
Q3 2021 | $15,000 | -21.1% | 234 | 0.0% | 0.00% | – |
Q2 2021 | $19,000 | +18.8% | 234 | 0.0% | 0.00% | – |
Q1 2021 | $16,000 | -11.1% | 234 | 0.0% | 0.00% | – |
Q4 2020 | $18,000 | +80.0% | 234 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | 0.0% | 234 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | +11.1% | 234 | -22.5% | 0.00% | – |
Q1 2020 | $9,000 | -40.0% | 302 | +29.1% | 0.00% | – |
Q4 2019 | $15,000 | +114.3% | 234 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | +250.0% | 234 | +185.4% | 0.00% | – |
Q1 2019 | $2,000 | – | 82 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |